Tvm Life Science Ventures Vi Gmbh & Co Kg - Net Worth and Insider Trading

Tvm Life Science Ventures Vi Gmbh & Co Kg Net Worth

The estimated net worth of Tvm Life Science Ventures Vi Gmbh & Co Kg is at least $2 Million dollars as of 2024-11-13. Tvm Life Science Ventures Vi Gmbh & Co Kg is the Director, 10% Owner of Acer Therapeutics Inc and owns about 2,397,309 shares of Acer Therapeutics Inc (ACER) stock worth over $2 Million. Tvm Life Science Ventures Vi Gmbh & Co Kg is also the Director, 10% Owner of Concert Pharmaceuticals Inc and owns about 53,097 shares of Concert Pharmaceuticals Inc (CNCE) stock worth over $444,422. Details can be seen in Tvm Life Science Ventures Vi Gmbh & Co Kg's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Tvm Life Science Ventures Vi Gmbh & Co Kg has not made any transactions after 2017-12-12 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Tvm Life Science Ventures Vi Gmbh & Co Kg

To

Tvm Life Science Ventures Vi Gmbh & Co Kg Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Tvm Life Science Ventures Vi Gmbh & Co Kg owns 3 companies in total, including Acer Therapeutics Inc (ACER) , Protara Therapeutics Inc (TARA) , and Concert Pharmaceuticals Inc (CNCE) .

Click here to see the complete history of Tvm Life Science Ventures Vi Gmbh & Co Kg’s form 4 insider trades.

Insider Ownership Summary of Tvm Life Science Ventures Vi Gmbh & Co Kg

Ticker Comapny Transaction Date Type of Owner
ACER Acer Therapeutics Inc 2017-12-12 director & 10 percent owner
TARA Protara Therapeutics Inc 2017-06-22 10 percent owner
CNCE Concert Pharmaceuticals Inc 2014-02-12 director & 10 percent owner

Tvm Life Science Ventures Vi Gmbh & Co Kg Latest Holdings Summary

Tvm Life Science Ventures Vi Gmbh & Co Kg currently owns a total of 2 stocks. Among these stocks, Tvm Life Science Ventures Vi Gmbh & Co Kg owns 2,397,309 shares of Acer Therapeutics Inc (ACER) as of December 12, 2017, with a value of $2 Million and a weighting of 78.07%. Tvm Life Science Ventures Vi Gmbh & Co Kg also owns 53,097 shares of Concert Pharmaceuticals Inc (CNCE) as of February 12, 2014, with a value of $444,422 and a weighting of 21.93%.

Latest Holdings of Tvm Life Science Ventures Vi Gmbh & Co Kg

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ACER Acer Therapeutics Inc 2017-12-12 2,397,309 0.66 1,582,464
CNCE Concert Pharmaceuticals Inc 2014-02-12 53,097 8.37 444,422

Holding Weightings of Tvm Life Science Ventures Vi Gmbh & Co Kg


Tvm Life Science Ventures Vi Gmbh & Co Kg Form 4 Trading Tracker

According to the SEC Form 4 filings, Tvm Life Science Ventures Vi Gmbh & Co Kg has made a total of 0 transactions in Acer Therapeutics Inc (ACER) over the past 5 years. The most-recent trade in Acer Therapeutics Inc is the acquisition of 333,333 shares on December 12, 2017, which cost Tvm Life Science Ventures Vi Gmbh & Co Kg around $4 Million.

According to the SEC Form 4 filings, Tvm Life Science Ventures Vi Gmbh & Co Kg has made a total of 0 transactions in Concert Pharmaceuticals Inc (CNCE) over the past 5 years. The most-recent trade in Concert Pharmaceuticals Inc is the sale of 0 shares on February 12, 2014, which brought Tvm Life Science Ventures Vi Gmbh & Co Kg around $0.

Insider Trading History of Tvm Life Science Ventures Vi Gmbh & Co Kg

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Tvm Life Science Ventures Vi Gmbh & Co Kg Trading Performance

GuruFocus tracks the stock performance after each of Tvm Life Science Ventures Vi Gmbh & Co Kg's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Tvm Life Science Ventures Vi Gmbh & Co Kg is 51.46%. GuruFocus also compares Tvm Life Science Ventures Vi Gmbh & Co Kg's trading performance to market benchmark return within the same time period. The performance of stocks bought by Tvm Life Science Ventures Vi Gmbh & Co Kg within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Tvm Life Science Ventures Vi Gmbh & Co Kg's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Tvm Life Science Ventures Vi Gmbh & Co Kg

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
1 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 52.46 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 47.88 LIMIT LIMIT LIMIT LIMIT LIMIT

Tvm Life Science Ventures Vi Gmbh & Co Kg Ownership Network

Ownership Network List of Tvm Life Science Ventures Vi Gmbh & Co Kg

No Data

Ownership Network Relation of Tvm Life Science Ventures Vi Gmbh & Co Kg

Insider Network Chart

Tvm Life Science Ventures Vi Gmbh & Co Kg Owned Company Details

What does Acer Therapeutics Inc do?

Who are the key executives at Acer Therapeutics Inc?

Tvm Life Science Ventures Vi Gmbh & Co Kg is the director & 10 percent owner of Acer Therapeutics Inc. Other key executives at Acer Therapeutics Inc include director & President and Chief Executive Chris Schelling , Chief Operating Officer Tanya Hayden , and Chief Medical Officer Adrian W Quartel .

Acer Therapeutics Inc (ACER) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Acer Therapeutics Inc (ACER) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Acer Therapeutics Inc (ACER) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Acer Therapeutics Inc (ACER)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Acer Therapeutics Inc Insider Transactions

No Available Data

Tvm Life Science Ventures Vi Gmbh & Co Kg Mailing Address

Above is the net worth, insider trading, and ownership report for Tvm Life Science Ventures Vi Gmbh & Co Kg. You might contact Tvm Life Science Ventures Vi Gmbh & Co Kg via mailing address: C/o Tvm Capital Group, Ottostrasse 4, Munich 2m 80333.